IHS Chemical Week

People & Business :: M&A

Amgen to Acquire a Leading Turkish API Producer

1:13 AM MDT | May 1, 2012 | Deepti Ramesh

Amgen (Thousand Oaks, CA) says it has signed an agreement to acquire 95.6% stake in Mustafa Nevzat Pharmaceuticals (Istanbul, Turkey), a privately held pharmaceutical company, for about $700 million. Mustafa Nevzat Pharmaceuticals is one of the leading manufacturers of active pharmaceutical ingredients (APIs) and finished dosage forms in Turkey. Mustafa Nevzat Pharmaceuticals had revenues of about $200 million in 2011 and has grown on average at double-digit rates in local currency over the past five years, Amgen says. The API manufacturing complex of Mustafa...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa